HomeCompareCMPOW vs MRK

CMPOW vs MRK: Dividend Comparison 2026

CMPOW yields 16.46% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMPOW wins by $914.00 in total portfolio value
10 years
CMPOW
CMPOW
● Live price
16.46%
Share price
$12.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$58.6K
Annual income
$4,527.13
Full CMPOW calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CMPOW vs MRK

📍 CMPOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMPOWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMPOW + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMPOW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMPOW
Annual income on $10K today (after 15% tax)
$1,399.18/yr
After 10yr DRIP, annual income (after tax)
$3,848.06/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $4,748.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMPOW + MRK for your $10,000?

CMPOW: 50%MRK: 50%
100% MRK50/50100% CMPOW
Portfolio after 10yr
$58.2K
Annual income
$7,320.46/yr
Blended yield
12.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CMPOW
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.4
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMPOW buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMPOWMRK
Forward yield16.46%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$58.6K$57.7K
Annual income after 10y$4,527.13$10,113.78
Total dividends collected$30.0K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CMPOW vs MRK ($10,000, DRIP)

YearCMPOW PortfolioCMPOW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,346$1,646.09$11,213$373.04+$1.1KCMPOW
2$15,110$1,899.33$12,667$512.06+$2.4KCMPOW
3$18,340$2,172.40$14,439$708.14+$3.9KCMPOW
4$22,088$2,464.31$16,640$988.16+$5.4KCMPOW
5$26,408$2,773.78$19,432$1,394.07+$7.0KCMPOW
6$31,356$3,099.32$23,057$1,992.90+$8.3KCMPOW
7$36,990$3,439.27$27,889$2,894.79+$9.1KCMPOW
8$43,371$3,791.83$34,518$4,286.29+$8.9KCMPOW
9$50,562$4,155.10$43,912$6,494.35+$6.7KCMPOW
10$58,628$4,527.13$57,714$10,113.78+$914.00CMPOW

CMPOW vs MRK: Complete Analysis 2026

CMPOWStock

CompoSecure, Inc. designs and manufactures payment cards worldwide. Its products portfolio includes Arculus, which provides key-based security by integrating digital security technology into customers platforms that protect password less login, multi-factor identity authentication, non-custodial crypto key management, and fraud reduction; and EMV chip and contactless metal cards, such as full metal, terra ceramics, metal hybrid, metal veneer, and embedded metal cards that can facilitate financial or loyalty transactions in open or closed-loop systems. The company also provides cryptocurrency and digital asset storage and security solutions. It serves luxury resorts and casinos, governments, and plastic card manufacturers, as well as financial services and luxury retail and gifting sectors. The company was incorporated in 2020 and is based in Burlingame, California.

Full CMPOW Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CMPOW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMPOW vs SCHDCMPOW vs JEPICMPOW vs OCMPOW vs KOCMPOW vs MAINCMPOW vs JNJCMPOW vs ABBVCMPOW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.